Reducing Risk of Severe Liver Injury in Patients Treated With Isoniazid.
Unidad de Gestión Clínica de Enfermedades Digestivas, Departmento de Medicina, Instituto de Investigación Biomédica de Málaga, Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga, Spain; Centro de Investigación Biomédica en Red de Enfermedades, Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
Raúl J
RJ
Andrade
D016907:Adverse Drug Reaction Reporting Systems; D000995:Antitubercular Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000453:epidemiology*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000453:epidemiology*; D005260:Female; D019983:Guideline Adherence; D006302:Health Services Research; D006801:Humans; D007538:Isoniazid / Q000009:adverse effects*; D008297:Male
D000995:Antitubercular Agents; D007538:Isoniazid